Cistanche deserticola-derived exosome-like nanovesicles target the Microbiota-GABA signaling axis to ameliorate loperamide-induced constipation
Frontiers in Pharmacology · 07.11.2025 · 16
DOI: 10.3389/fphar.2025.1693366 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 07.11.2025. Verfasst von Xiaoyu Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: College of Clinical Medicine of Hubei University of Chinese Medicine, Wuhan, China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Health Commission of Hubei Province, Department of Science and Technology of Hubei Province.
Abstract (Originalsprache)
Introduction
Constipation is a prevalent gastrointestinal disorder with limited therapeutic options that often lead to laxative dependence. Gut microbiota and their metabolic regulation represent promising therapeutic targets.
Methods
In this study, we isolated and characterized exosome-like nanovesicles from the traditional Chinese herb Cistanche deserticola (CELNs) and evaluated their efficacy in a loperamide-induced mouse model of constipation.
Results
We found that CELNs administration significantly alleviated constipation phenotypes, as evidenced by increased fecal output, water content, and intestinal transit rate, alongside the restoration of colonic histology and goblet cell function. Multiomic analyses revealed that CELNs remodeled the gut microbiota by enriching GABA-producing genera, such as Lactobacillus and Bacteroides , consequently elevating intestinal GABA levels. This increased GABA specifically activated GABA A receptor subunits α2 and β2/3, thereby enhancing intestinal smooth muscle contraction. Crucially, the therapeutic effects of CELNs were entirely abolished by a GABA A R antagonist, confirming that their action is dependent on GABA A R signaling activation.
Discussion
In summary, our study reveals a novel mechanism through which CELNs enhance intestinal motility via the microbiota–metabolite–host axis, offering a conceptual foundation and a potential nanotherapeutic strategy for the targeted treatment of constipation by modulating microbial homeostasis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Clinical Medicine of Hubei University of Chinese Medicine, Wuhan, China.
- Department of Anorectal Medicine, Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, China.
- Hubei Shizhen Laboratory, Wuhan, China.
Förderung
- National Key Research and Development Program of China
- Health Commission of Hubei Province
- Department of Science and Technology of Hubei Province
Zitieren
APA
Zhang, X., Yan, K., Bao, X., Yang, D., Chen, X., Xiao, W., Zhou, J., Cai, Y., Wang, H., Sun, G., & Lin, A. (2025). Cistanche deserticola-derived exosome-like nanovesicles target the Microbiota-GABA signaling axis to ameliorate loperamide-induced constipation. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1693366
Vancouver
Zhang X, Yan K, Bao X, Yang D, Chen X, Xiao W, et al. Cistanche deserticola-derived exosome-like nanovesicles target the Microbiota-GABA signaling axis to ameliorate loperamide-induced constipation. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1693366
BibTeX
@article{Zhang2025,
author = {Zhang, Xiaoyu and Yan, Keqiu and Bao, Xinkun and Yang, Dequn and Chen, Xiaoyin and Xiao, Wenjie and Zhou, Jinbo and Cai, Yifan and Wang, Hao and Sun, Guangjun and Lin, Aizhen},
title = {Cistanche deserticola-derived exosome-like nanovesicles target the Microbiota-GABA signaling axis to ameliorate loperamide-induced constipation},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1693366}
}
EUVIMED